Skip to main content
SpringerLink
Log in
Book cover

Atlas of the Prostate pp 163–170Cite as

Permanent Seed Interstitial Prostate Brachytherapy

  • Chapter

  • 239 Accesses

Abstract

Permanent implant prostate brachytherapy first gained popularity in the 1970s but subsequently underwent more than a 10-year period of near abandonment. Loss of interest in the technique stemmed from technical limitations of the retropubic approach that often resulted in poor physical distribution of the implanted seeds. This, together with inappropriately chosen patients, often led to poor long-term results and a loss of enthusiasm for the technique. Improving external beam and surgical techniques also contributed to this shift in emphasis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Locke J, Ellis W, Wallner K, et al.: Risk factors for acute urinary retention requiring 16. temporary intermittent catheterization after prostate brachytherapy: a prospective study. Intl Radiat Oncol Biol Phys 2002, 52: 712–719.

    Article  Google Scholar 

  2. Terk MD, Stock RG, Stone NN: Identification of patients at increased risk for 17. prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998, 160: 1379–1382.

    Article  PubMed  CAS  Google Scholar 

  3. Wallner K, Smathers S, Sutlief S, et al.: Prostate brachytherapy in patients with median lobe hyperplasia. Int J Cancer 2000, 90:152–156. 18.

    Google Scholar 

  4. Blasko JC, Ragde H, Grimm PD: Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl 1991, 137: 113–118. 19.

    Google Scholar 

  5. Stone NN, Ratnow ER, Stock RG: Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation. Tech Urol 2000, 6: 123–127.

    PubMed  CAS  Google Scholar 

  6. Partin AW, Mangold LA, Lamm DM, et al.: Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001, 58: 843–848.

    Article  PubMed  CAS  Google Scholar 

  7. Blasko JC, Grimm PD, Sylvester JE, et al.: The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol 2000, 57:273–278.

    Google Scholar 

  8. Ling CC: Permanent implants using Au-198, Pd-103 and 1–125: radiobiological considerations based on the linear quadratic model. Intl Radiat Oncol Biol Phys 1992, 23: 81–87.

    Article  CAS  Google Scholar 

  9. Fowler J, Chappell R, Ritter M: Is alpha/beta for prostate tumors really low? Intl Radiat Oncol Biol Phys 2001, 50: 1021–1031.

    Article  CAS  Google Scholar 

  10. Cha CM, Potters L, Ashley R, etal.: Isotope selection for patients undergoing prostate brachytherapy. IntJ Radiat Oncol Biol Phys 1999, 45: 391–395.

    CAS  Google Scholar 

  11. Lee LN, Stock RG, Stone NN: Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation. Intl Radiat Oncol Biol Phys 2002, 52: 444 452.

    Google Scholar 

  12. Sharkey J, Chovnick SD, Behar RJ, et al.: Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy. J Endourol 2000, 14:343–350.

    Google Scholar 

  13. Stock RG, Stone NN, Tabert A, et al.: A dose-response study for 1–125 prostate implants. Intl Radiat Oncol Biol Phys 1998, 41:101–108.

    Google Scholar 

  14. Grimm PD, Blasko JC, Sylvester JE, et al.: 10-Year biochemical prostate-specific antigen control of prostate cancer with (125)1 brachytherapy. IntJ Radiat Oncol Biol Phys 2001, 51: 31–40.

    CAS  Google Scholar 

  15. Beyer DC, Brachman DG: Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy. Radiother Oncol 2000, 57: 263–267.

    Article  PubMed  CAS  Google Scholar 

  16. Ragde H, Korb LJ, Elgamal AA, et al.: Modern prostate brachytherapy: prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer2000, 89:135–141.

    Google Scholar 

  17. Grado GL, Larson TR, Balch CS, et al.: Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Intl Radiat Oncol Biol Phys 1998, 42:289–298.

    Google Scholar 

  18. Stock RG, Stone NN: The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy. Semin Surg Oncol 1997, 13: 454–460.

    Article  PubMed  CAS  Google Scholar 

  19. Zelefsky MJ, Hollister T, Raben A, etal.: Five-year biochemical outcome and toxicity with transperineal CT- planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radial Oncol Biol Phys 2000, 47: 1261–1266.

    Article  CAS  Google Scholar 

  20. Critz FA, Williams WH, Levinson AK, et al.: Simultaneous irradiation for prostate cancer: intermediate results with modern techniques. J Urol2000, 164: 738–741.

    Google Scholar 

  21. Kestin LL, Martinez AA, Stromberg JS, etal.: Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol 2000, 18: 2869–2880.

    PubMed  CAS  Google Scholar 

  22. Mate TP, Gottesman JE, Hatton J, etal.: High dose-rate afterloading 1922Iridium prostate brachytherapy: feasibility report. Intl Radiat Oncol Biol Phys 1998, 41: 525–533.

    Article  CAS  Google Scholar 

  23. Galalae RM, Kovacs G, Schultze J, et al.: Long-term outcome after elective irradi¬ation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Intl Radiat Oncol Biol Phys 2002, 52: 81–90.

    Article  Google Scholar 

  24. Mate TP, Gottesman JE, Hatton J, et al.: High dose-rate afterloading 192 Iridium prostate brachytherapy: feasibility report. Intl Radiat Oncol Biol Phys 1998, 41: 525–533.

    Article  CAS  Google Scholar 

  25. Syed AM, Puthawala A, Sharma A, et al.: High-dose-rate brachytherapy in the treatment of carcinoma of the prostate. Cancer Control 2001, 8: 511–521.

    PubMed  CAS  Google Scholar 

  26. Martinez AA, Pataki I, Edmundson G, et al.: Phase!! prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Intl Radiat Oncol Biol Phys 2001, 49: 61–69.

    Article  CAS  Google Scholar 

  27. Yoshioka Y, Nose T, Yoshida K, etal.: High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/11 clinical trial. Int.) Radiat Oncol Biol Phys 2000, 48: 675–681.

    Article  CAS  Google Scholar 

  28. Brenner DJ, Martinez A, Edmundson GK, et al.: Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Intl Radiat Oncol Biol Phys 2002, 52: 6–13.

    Article  Google Scholar 

Download references

Authors
  1. Mark A. Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Urology, University of Wisconsin-Madison Medical School, Madison, Wisconsin, USA

    Reginald C. Bruskewitz MD (Professor of Surgery) (Professor of Surgery)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Current Medicine, Inc.

About this chapter

Cite this chapter

Ritter, M.A. (2003). Permanent Seed Interstitial Prostate Brachytherapy. In: Bruskewitz, R.C. (eds) Atlas of the Prostate. Current Medicine Group, London. https://doi.org/10.1007/978-1-4615-6505-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6505-5_13

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4615-6507-9

  • Online ISBN: 978-1-4615-6505-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation